Advertisement

Topics

Bluebird Pushes For Zynteglo Pricing Of Five €315K Annual Installments

04:02 EDT 14 Jun 2019 | SCRIP

CEO Nick Leschly talked to Scrip about the European payment strategy for the one-time gene therapy, which will cost €1.575m...

      

Related Stories

 

Original Article: Bluebird Pushes For Zynteglo Pricing Of Five €315K Annual Installments

NEXT ARTICLE

More From BioPortfolio on "Bluebird Pushes For Zynteglo Pricing Of Five €315K Annual Installments"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...